Results
eNauka >
Rezultati >
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study
| Naziv: | Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study | Autori  : | Matteo Santoni; Zin W Myint; Thomas Büttner; Hideki Takeshita; Yohei Okada; Elaine T Lam; ... et al; Popovic, Lazar S   ; (broj, koautora 43) |
Godina: | 2023 | Publikacija: | CANCER IMMUNOLOGY IMMUNOTHERAPY | ISSN: | 0340-7004 Cancer Immunology Immunotherapy Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 72 br. 9 str. 2961-2970 | DOI: | 10.1007/s00262-023-03469-5 | WoS-ID: | 000999295300003 | Scopus-ID: | 2-s2.0-85160408484 | PMID: | 37248424 | URI: | https://enauka.gov.rs/handle/123456789/809009 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21M21 - Vodeći međunarodni časopis kategorije M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.